A Study of Olezarsen Administered Subcutaneously to Participants With Severe Hypertriglyceridemia

Clinical trial NCT05552326 · COMPLETED

Trial details

NCT number: NCT05552326
Sponsor: Ionis Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Severe Hypertriglyceridemia

Start date: 2022-08-31
Primary completion: 2024-12-17
Enrollment: 446

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.